SCHEMBL20123958

SCHEMBL20123958

CC/C(C)=C/C=C\c1ccc2ccc(CCc3nc4ccccn4n3)nc2c1C

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 13/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12067575 0.70 PDE10A (0.52) PDE10A
SCHEMBL15033445 0.69 PDE10A (0.65) PDE10A
SCHEMBL18911313 0.65 PDE10A (0.49) PDE10A
SCHEMBL10271750 0.62 JAK2 (0.46) PDE10A
SCHEMBL7147342 0.62 PDE10A (0.46) PDE10A
SCHEMBL11413826 0.60 PDE10A (0.44) PDE10A
SCHEMBL14006974 0.60 LMNA (0.49) PDE10A
SCHEMBL15959361 0.60 PARP1 (0.36)
SCHEMBL14352211 0.60 PDE10A (0.46) PDE10A
SCHEMBL2717765 0.59 JAK2 (0.46) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3318561-B1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC (US) 2021-12-22 EP disclosed
EP-2576540-B1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC (US) 2019-09-04 EP disclosed
EP-3318561-A1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF Sunovion Pharmaceuticals Inc. (US) 2018-05-09 EP disclosed